<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000572245"><TermName>Totect</TermName><TermPronunciation>(TOH-tekt)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat the toxic effects of an anticancer drug that leaks from a vein into surrounding tissue and causes tissue damage. It is also being studied in the treatment of cancer. Totect contains the active ingredient dexrazoxane. It is a type of chemoprotective agent, a type of cardioprotective agent, and a type of topoisomerase inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720783" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Totect&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720782" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Totect&quot;" language="es" id="_4"/><SpanishTermName>Totect</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar los efectos tóxicos de un medicamento anticanceroso que se escapa de las venas hacia el tejido cercano, dañando dichos tejidos. Asimismo, se encuentra en estudio para el tratamiento de cáncer. Totect contiene el ingrediente activo dexrazoxano. Es un tipo de quimioprotector, de cardioprotector, e inhibidor de la topoisomerasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-10-05</DateFirstPublished><DateLastModified>2008-06-26</DateLastModified></GlossaryTerm>
